The National Institute on Drug Abuse is soliciting proposals from qualified organizations capable of having in-house capability to develop methodologies and to perform in vivo rodent behavioral pharmacology for cocaine and other drug dependence disorders, using drug self-administration reinstatement models. The objectives of this contract are to determine the in vivo efficacy of novel compounds in animal models of relapse.